… Rosuvastatin group was added with rosuvastatin tablet 10 mg-d'1 (specification: 10 mg per
tablet, drug batch number: JC880).Atorvastatin group was added with atorvastatin tablet 20 …

… ated the efficacy of rosuvastatin and atorvastatin in reducing LDL-C and nonHDL cholesterol
along with the safety profiles of the drugs. Subgroup analysis evaluated the difference in …

… properties than commercially available Rosuvastatin salt. The objective of the present
study is to evaluate safety, tolerability, and … Impact of biomarker development on drug safety …

… evaluate the pharmacokinetics of rosuvastatin from RCTs that included mainly bioequivalence
and drug–drug … rate and extent of absorption of rosuvastatin. Bioequivalence studies, in …

… ApoB/ApoA1 ratio with rosuvastatin and atorvastatin; safety evaluation with rosuvastatin 5 mg
and 10 mg; … However, both doses of rosuvastatin were safe and well tolerated in our study. …

… of rosuvastatin in Bangladesh has not been adequately studied. Therefore, this study was
conducted to understand the efficacy and safety of rosuvastatin in … and safety of rosuvastatin …

… In this study conducted at Government Medical College, Suryapet, we aimed to evaluate
the effectiveness and safety of rosuvastatin therapy in individuals with dyslipidemia. …

… , drug–disease interactions also play an important role in determining drug safety profile. …
and pitavastatin and 20 mg or greater for rosuvastatin. Statistical analysis was performed by the …

… Overall, these results suggest that rosuvastatin use increased the risk of QT … rosuvastatin
treatment was not associated with mortality. In conclusion, while our study links rosuvastatin use …

… been conducted to assess the efficacy and safety of rosuvastatin generics in a real-life setting…
to assess the safety and efficacy of a generic formulation of rosuvastatin in reducing plasma …